Elder Pharmaceuticals will be investing Rs 15-20 crore over the next two-three years for its foray into cosmetics, an official has said.

"We are looking at investment of Rs 15-20 crore over the next two-three years for marketing and man...
Read more >>

Drug firm Elder Pharmaceuticals has formed a joint venture with Japan\'s Kose Corporation to manufacture and sell cosmetics in India.

Kose Corporation is one of the leading Japanese cosmetic companies.

"Kose products will be pro...
Read more >>

Elder Pharmaceuticals on Monday signed an agreement with Russia"s Holding PharmaEco for bilateral co-operation in the healthcare sector.

The memorandum of understanding (MoU) was signed as part of Russian President Vladimir Putin"s visit...
Read more >>

Elder Pharmaceuticals Ltd, a Mumbai based Rs.1300 crore plus pharmaceutical company, has received the Certificate of Suitability (COS) from European Directorate for the Quality of Medicines and Healthcare (EDQM), for Diosmin API.

EDQM is a...
Read more >>

Elder Pharmaceuticals, an integrated pharmaceuticals company, has posted 22 per cent rise in its consolidated net profit at Rs 23.60 crore for the quarter ended September 2012 compared to Rs 19.35 crore for the corresponding period previous year. ...
Read more >>

Honorable Joint Managing Director Mr Alok Saxena has been bestowed with "Brand Slam Leadership Award" on 13th Oct, 2012 by Indira Group of Institutes, Pune. The award is given in recognition of Brand Management, Brand Leadership & Innovation. Read more >>

The shareholders of Elder Pharmaceuticals Ltd (NSE- ELDERPHARM), one of the fastest growing integrated pharmaceuticals company in the country have approved a final dividend of Rs. 3 per share of face value Rs. 10 at the rate of 30% for the financi...
Read more >>

Drug firm Elder Pharma is focusing on enhancing its presence in pain management and treatment of chronic diseases as part of strategy to grow its in-licensed products portfolio.

Drug firm Elder Pharma is focusing on enhancing its presence ...
Read more >>

Launched Zalain to treat fungal skin infections, plans to launch upto five nutraceutical products in India through partnerships with international firms in 6 months.

Elder Pharmaceuticals today said it has launched 'Zalain', a medicine u...
Read more >>

Elder Pharmaceuticals today reported 7.23% increase in its consolidated net profit at Rs 18.52 crore for the quarter ended March 31, 2012 mainly on account of reduction in material costs.

The company had posted a net profit of Rs 17.27 cro...
Read more >>

Elder Pharmaceuticals Ltd, one of the fastest growing pharmaceutical companies in the country, in association with New York based Combe Inc., a global brand leader in feminine care, has launched the Vagisil range of feminine personal hygiene produ...
Read more >>

Elder Pharmaceuticals, a Rs.950 crore plus Mumbai based pharma major, has reported satisfactory performance during the third quarter ended December 2011 and its net profit increased by 15.5 per cent to Rs.18.29 crore from Rs.15.94 crore in the sam...
Read more >>

SMC Global has picked up Elder Pharmaceuticals as its techno-funda call. It has recommended to Buy around Rs 363.50 for target price of Rs 385-405 (duration: 2 months) and stop loss of Rs 345. The broking firm gave following rationale:

The...
Read more >>

Drug firm Elder Pharmaceuticals plans to launch eight new products in the country in various therapeutic areas, including gynaecology and pain management, in the remaining half of the current fiscal.

\"We have already launched seven ne...
Read more >>

Boosted by strong growth in women healthcare segment, Elder Pharmaceutical's consolidated net profit rose by 42.12 per cent to Rs 19.23 crore for the second quarter ended September 30, 2011, over the same period previous fiscal.

The compa...
Read more >>

Drug firm Elder Pharmaceuticals today said it plans to foray into the growing personal and lifestyle healthcare sector including hypertension, diabetes and cardiac care.

Elder's main strength is marketing the women\'s healthcare produc...
Read more >>

Elder Pharmaceuticals today said its shareholders have approved a final dividend of 30 per cent for the financial year ended March 31, 2011.

Shareholders at the company\'s annual general meeting (AGM) held today have approved a final div...
Read more >>

Drug firm Elder Pharmaceuticals will launch 12 new products this fiscal in the areas of gynecology, pain management and nutraceuticals.

"We had targeted 15 products for this financial year, three have already been launched and we are look...
Read more >>